Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: Milan who wrote (17)	1/13/1998 1:40:00 PM
From: August James	Read Replies (1) \| Respond to of 410

Attention doctors: I would like to know if anyone has compared AVEI stents to GDT's stints. Doesn't GDT's stints have a rapid exchage feature and AVEI's don't? (I understand that due to patent issues AVEI can't use rapid exchange in US) Could you also elaborate on the rapid exchange feature, what exactly does this mean or do? Also, JNJ has next generation stint out. How does this compare to AVEI and GDT? It seems to me that these are becoming more and more a commodity. I would think JNJ could come up with a competitive stint most cost effectively through R&D vs. buying out AVEI.